Skip to main content
. 2023 May 18:1–8. Online ahead of print. doi: 10.1007/s13187-023-02312-w

Table 3.

Delays in Cancer Preventiona

Limited HL Adequate HL All Participants P-value
Mammogram, n (%) N = 84 N = 480 N = 564
  Do not know/ not sure 2 (2.4%) 3 (0.63%) 5 (0.89%) 0.246
  No, not delayed 61 (72.6%) 368 (76.7%) 429 (76.1%)
  Yes, delayed 21 (25.0%) 109 (22.7%) 130 (23.0%)
    Rescheduled or already completed 7 (33.3%) 14 (12.8%) 21 (16.2%) 0.724
    Not yet rescheduled 14 (66.7%) 95 (87.2%) 109 (83.8%)
Pap smear, n (%) N = 34 N = 221 N = 255
  Do not know/ not sure 0 (0%) 4 (1.8%) 4 (1.6%) 0.707
  No, not delayed 25 (73.5%) 164 (74.2%) 189 (74.1%)
  Yes, delayed 9 (26.5%) 53 (24.0%) 62 (24.3%)
    Rescheduled or already completed 3 (33.3%) 30 (56.6%) 33 (53.2%) 0.196
    Not yet rescheduled 6 (66.7%) 23 (43.4%) 29 (46.8%)
Colonoscopy, n (%) N = 39 N = 164 N = 203
  Do not know/ not sure 3 (7.7%) 1 (0.61%) 4 (2.0%) 0.012
  No, not delayed 23 (59.0%) 115 (70.1%) 138 (68.0%)
  Yes, delayed 13 (33.3%) 48 (29.3%) 61 (30.0%)
    Rescheduled or already completed 5 (38.5%) 19 (39.6%) 24 (39.3%) 0.941
    Not yet rescheduled 8 (61.5%) 29 (60.4%) 37 (60.7%)

a Among participants who were planning on having a cancer prevention screening between March 1st, 2020 and December 31st, 2020

Percentages are calculated among the bolded total per screening modality per health literacy group